Topics

AbbVie’s Skyrizi Tops Novartis’s Cosentyx In Psoriasis Contest

06:00 EST 15 Jan 2020 | SCRIP

A Phase III clinical trial comparing AbbVie's Skyrizi with Novartis's IL-17 agonist Cosentyx showed the former's superiority in adults with...

      

Related Stories

 

Original Article: AbbVie’s Skyrizi Tops Novartis’s Cosentyx In Psoriasis Contest

NEXT ARTICLE

More From BioPortfolio on "AbbVie’s Skyrizi Tops Novartis’s Cosentyx In Psoriasis Contest"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...